Concord Drugs Ltd
CONCORDConcord Drugs Ltd
CONCORD
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 21.15 | 1.11 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.46 | 5.11 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Concord Drugs is a pharmaceutical company, engaged in the manufacture of pharmaceutical formulations and the trading of packing material
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 40.39 | 50.88 | 57.58 | 51.94 | 48.17 | 51.46 | 55.22 | 59.06 | 52.09 | 42.34 | ||||||||||
Raw Materials | 31.90 | 39.22 | 46.51 | 46.50 | 39.14 | 42.06 | 41.28 | 44.41 | 41.16 | 36.85 | ||||||||||
| Power & Fuel Cost | 0.34 | 0.77 | 0.97 | 0.70 | 0.78 | 0.77 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.44 | 1.61 | 2.57 | 1.73 | 2.29 | 3.27 | 3.47 | 4.14 | 3.84 | |||||||||||
| Selling & Administrative Expenses | 0.56 | 0.60 | 1.84 | 0.97 | 0.77 | 0.95 | 1.03 | 1.53 | 2.10 | |||||||||||
| Operating & Other expenses | -0.24 | 0.23 | 0.10 | -2.89 | 1.44 | 0.95 | 2.36 | 3.28 | 0.40 | |||||||||||
EBITDA | 7.39 | 8.45 | 5.59 | 4.93 | 3.75 | 3.46 | 7.08 | 5.70 | 4.59 | 5.49 | ||||||||||
| Depreciation/Amortization | 3.63 | 2.91 | 2.58 | 2.40 | 1.71 | 1.46 | 1.37 | 1.76 | 1.63 | 1.48 | ||||||||||
| PBIT | 3.76 | 5.54 | 3.01 | 2.53 | 2.04 | 2.00 | 5.71 | 3.94 | 2.96 | 4.01 | ||||||||||
| Interest & Other Items | 2.72 | 2.57 | 2.36 | 1.88 | 1.59 | 1.54 | 1.42 | 1.68 | 1.71 | 1.82 | ||||||||||
| PBT | 1.04 | 2.97 | 0.65 | 0.65 | 0.45 | 0.46 | 4.29 | 2.26 | 1.25 | 2.19 | ||||||||||
| Taxes & Other Items | 0.35 | 1.21 | 0.48 | 0.32 | 0.04 | 0.13 | 1.01 | 0.65 | 0.26 | 0.52 | ||||||||||
| Net Income | 0.69 | 1.76 | 0.17 | 0.33 | 0.41 | 0.33 | 3.28 | 1.61 | 0.99 | 1.67 | ||||||||||
| EPS | 0.95 | 2.43 | 0.23 | 0.44 | 0.52 | 0.40 | 3.75 | 1.84 | 1.10 | 1.79 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Concord Drugs Ltd | 35.68 | 1.11 | — |
| Sun Pharmaceutical Industries Ltd | 35.10 | 5.01 | 0.93% |
| Cipla Ltd | 35.28 | 4.17 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.34 | 4.13 | 0.69% |
Price Comparison
Compare CONCORD with any stock or ETFShareholdings
Promoter Holdings Trend
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2023
Jun 2023
Sep 2023
Oct 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
CONCORD has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Concord Drugs standalone net profit rises 7.14% in the December 2022 quarter
9 months ago•Business Standard
Stocks that will see action on September 9, 2022
1 year ago•The Hindu Businessline
Concord Drugs standalone net profit rises 475.00% in the September 2021 quarter
2 years ago•Business Standard
Concord Drugs standalone net profit rises 183.33% in the March 2021 quarter
2 years ago•Business Standard
Markets likely to witness lacklustre trade; eyes RBI’s monetary policy
2 years ago•The Hindu Businessline
Buzzing Stocks | HDFC, IRCTC, Zee Media, Canara Bank, Adani Ports, IRCON, VST Tillers
2 years ago•Moneycontrol
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 0.06%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.03% to 0.02%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 24.57%, vs industry avg of 9.82%